Parabolic Drugs (Delisted) share news and announcements

BSE: 533211Pharmaceuticals & Biotechnology

Last traded ₹5.50 on 25 Jan 2021

Delisted on 11 Aug 2021.

Parabolic Drugs share news and announcements

677 announcements, routine notices left out, newest first. Page 3 of 14.

Jan 2019
- 7 Jan · Corporate Insolvency Resolution Process
  Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Insolvency Resolution Process for Corporate Persons) Regulations, 2016, the third meeting of Committee of Creditors ("CoC") of the Corporate Debtor is scheduled to be held on January 5, 2018. (opens in a new tab)
- 5 Jan · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
  This is to inform you that pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Insolvency Resolution Process for Corporate Persons) Regulations, 2016, the third meeting .... (opens in a new tab)
- 2 Jan · Legal
  Exchange had sought clarification from Parabolic Drugs Limited with respect to announcement dated 17-Dec-2018, regarding " Parabolic Drugs Limited has informed the Exchange regarding Change in Auditors of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)2. Date of appointment/cessation (as applicable) & term of appointmentThe response of the Company is attached. (opens in a new tab)
Dec 2018
- 20 Dec · Legal
  Exchange has sought clarification from Parabolic Drugs Limited with respect to announcement dated 17-Dec-2018, regarding " Parabolic Drugs Limited has informed the Exchange regarding Change in Auditors of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment) 2. Date of appointment/cessation (as applicable) & term of appointment The response of the Company is awaited.
- 19 Dec · Updates
  Claims for the Corporate Insolvency resolution Process of M/s Parabolic Drugs Ltd (opens in a new tab)
- 17 Dec · Corporate Insolvency Resolution Process
  Outcome of third meeting of Committee of Creditors ( CoC) of the Corporate Debtor (opens in a new tab)
- 17 Dec · Management
  In terms of Section 140 of the Companies Act, 2013, V.K. Jindal & Associates, Chartered Accountants has resigned from the Company as statutory Auditors w.e.f. 01st October, 2018 due to .... (opens in a new tab)
- 17 Dec · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Outcome of third meeting of Committee of Creditors ('CoC') of the Corporate Debtor (opens in a new tab)
- 17 Dec · Management
  Change in Auditors of the company. (opens in a new tab)
Nov 2018
- 27 Nov · Corporate Insolvency Resolution Process
  Pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Insolvency Resolution Process for Corporate Persons) Regulations, 2016, the third meeting of Committee of Creditors ("CoC") of the Corporate Debtor is scheduled to be held on November 29, 2018 inter-alia to consider and approve the following agenda items as per given below Attachments. (opens in a new tab)
- 27 Nov · Legal
  Exchange had sought clarification from Parabolic Drugs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone limited review report not submitted The response of the Company is attached. (opens in a new tab)
- 26 Nov · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
  This is to inform you that pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI (Insolvency Resolution Process for Corporate Persons) Regulations, 2016, the third meeting .... (opens in a new tab)
- 20 Nov · Legal
  Exchange has sought clarification from Parabolic Drugs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone limited review report not submitted The response of the Company is awaited.
- 14 Nov · Corporate Insolvency Resolution Process
  Outcome of second meeting of committee of creditors of Parabolic Drugs Limited (opens in a new tab)
- 14 Nov · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Outcome of second meeting of Committee of Creditors ("CoC") of the Corporate Debtor (opens in a new tab)
- 14 Nov · Results
  Dear Sir/ Ma'am, Pursuant to the Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Un-audited Financial Results .... (opens in a new tab)
- 14 Nov · Results
  Financial results for the period ended September 30, 2018. (opens in a new tab)
- 9 Nov · Management
  Resignation of Mr VK Jindal and associates as statutory auditors of the company w.e.f. October 01, 2018. (opens in a new tab)
- 9 Nov · Board meeting
  To consider and approve the Un-audited Financial Results for the Quarter and half year ended on September 30,2018. (opens in a new tab)
- 8 Nov · Management
  This is to inform you that M/s. V.K. Jindal & Associates, Chartered Accountants, .... (opens in a new tab)
- 6 Nov · Corporate Insolvency Resolution Process
  Notice of second meeting of Committee of Creditors of the Parabolic Drugs Limited "Corporate Debtor'. (opens in a new tab)
- 6 Nov · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
  This is to inform you that pursuant to the provisions of Regulations 17, 19 and 20 of the IBBI(Insolvency Resolution Process for Corporate Persons) Regulations, 2016, the second meeting .... (opens in a new tab)
Oct 2018
- 30 Oct · Legal
  Exchange had sought clarification from Parabolic Drugs Limited with respect to announcement dated 19-Oct-2018, regarding " Parabolic Drugs Limited has informed the Exchange that Intimation regarding change of IRP and appointment of RP in the matter of Corporate Insolvency Resolution Process (CIRP) Of Parabolic Drugs Limited.".On basis of above the Company is required to clarify following:1. Any other material information not involving commercial secrets 2. Salient features, not involving commercial secrets, of the resolution plan approved by the Tribunal, in such form as may be specified 3. Approval of resolution plan by the Tribunal or rejection, if applicable 4. Filing of resolution plan with the Tribunal 5. Number of resolution plan with the Tribunal 6. Brief particulars of invitation of resolution plans under section 25(2)(h) of Insolvency Code in the Form specified under regulation 36A(5) of IBBI (Insolvency Resolution Process for Corporate Persons) Regulations,2016 7. Prior or post-facto intimation of the meetings of Committee of Creditors 8. Appointment/Replacement of the Resolutions Professional 9. List of creditors as required to be displayed by the corporate debtor under regulation 13(2)(c) of the IBBI (Insolvency Resolution process for Corporate Persons ) Regulations.2016 10. Public announcement made pursuant to order passed by the Tribunal under section 13 of Insolvency Code 11. Admission of application by the Tribunal, along with amount of default or rejection or withdrawal, as applicable 12. Filing of application by financial creditors for initiation of CIRP against the corporate debtor, also specifying the amount of default 13. Filing of application by financial creditors for initiation of CIRP also specifying the amount of default The response of the Company is attached. (opens in a new tab)
- 30 Oct · Compliance Certificate For Period Ended 30.09.2018
  We are enclosing herewith Compliance Report on Transfer or Transmission or .... (opens in a new tab)
- 30 Oct · Compliance Certificate For Period Ending 30-09-2018
  Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015 please find enclosed the certificate from Link Intime India Private Limited (Registrar Share .... (opens in a new tab)
- 23 Oct · Shareholding for the Period Ended September 30, 2018
  Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....
- 22 Oct · Legal
  Exchange has sought clarification from Parabolic Drugs Limited with respect to announcement dated 19-Oct-2018, regarding " Parabolic Drugs Limited has informed the Exchange that Intimation regarding change of IRP and appointment of RP in the matter of Corporate Insolvency Resolution Process (CIRP) Of Parabolic Drugs Limited.". On basis of above the Company is required to clarify following: 1. Any other material information not involving commercial secrets 2. Salient features, not involving commercial secrets, of the resolution plan approved by the Tribunal, in such form as may be specified 3. Approval of resolution plan by the Tribunal or rejection, if applicable 4. Filing of resolution plan with the Tribunal 5. Number of resolution plan with the Tribunal 6. Brief particulars of invitation of resolution plans under section 25(2)(h) of Insolvency Code in the Form specified under regulation 36A(5) of IBBI (Insolvency Resolution Process for Corporate Persons) Regulations,2016 7. Prior or post-facto intimation of the meetings of Committee of Creditors 8. Appointment/Replacement of the Resolutions Professional 9. List of creditors as required to be displayed by the corporate debtor under regulation 13(2)(c) of the IBBI (Insolvency Resolution process for Corporate Persons ) Regulations.2016 10. Public announcement made pursuant to order passed by the Tribunal under section 13 of Insolvency Code 11. Admission of application by the Tribunal, along with amount of default or rejection or withdrawal, as applicable 12. Filing of application by financial creditors for initiation of CIRP against the corporate debtor, also specifying the amount of default 13. Filing of application by financial creditors for initiation of CIRP also specifying the amount of default The response of the Company is awaited.
- 22 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 19 Oct · Corporate Insolvency Resolution Process
  Intimation regarding change of IRP and appointment of RP in the matter of Corporate Insolvency Resolution Process (CIRP) Of Parabolic Drugs Limited. (opens in a new tab)
- 18 Oct · Corporate Insolvency Resolution Process (CIRP)-Replacement of Interim Resolution Professional (IRP)
  Intimation regarding Change of IRP and Appointment of resolution professional in the matter of Corporate Insolvency Resolution Process of Parabolic Drugs Limited. (opens in a new tab)
- 13 Oct · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 1 Oct · Meeting
  Proceedings of Annual General Meeting held on September 29, 2018 (opens in a new tab)
Sep 2018
Aug 2018
- 23 Aug · Legal
  Exchange had sought clarification from Parabolic Drugs Limited with respect to announcement dated 14-Aug-2018, regarding " Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on August 14, 2018.".On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment); The response of the Company is attached. (opens in a new tab)
- 21 Aug · Legal
  Exchange has sought clarification from Parabolic Drugs Limited with respect to announcement dated 14-Aug-2018, regarding " Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on August 14, 2018.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is awaited.
- 14 Aug · Results
  Sir/Madam Pursuant to Regulation 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the UN-Audited Financial .... (opens in a new tab)
- 14 Aug · Results
  Financial results for the period ended June 30, 2018. (opens in a new tab)
- 14 Aug · Board meeting
  This is to inform you that the Board of Directors in its Meeting held on 14th August, 2018 and concluded at 19:10 : Approved the Unaudited Financial Results of the Company for the Quarter .... (opens in a new tab)
- 14 Aug · Board meeting
  Board meeting held on August 14, 2018. (opens in a new tab)
- 6 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve Pursuant to the Regulation .... (opens in a new tab)
- 6 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018 (opens in a new tab)
Jul 2018
- 21 Jul · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
  This is to inform you that the Board of Directors in its Meeting held on 21st July, 2018 and concluded at 03:10 p.m. Considered and approved the change of registered/Corporate office of .... (opens in a new tab)
- 21 Jul · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
  This is to inform you that the Board of Directors in its Meeting held on 21st July, 2018 and concluded at 03:10 p.m.:Considered and approved the change of registered/Corporate office of .... (opens in a new tab)